These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 872142

  • 21. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K, Blechman WJ, Riddle VG, Pardee AB.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [Abstract] [Full Text] [Related]

  • 22. The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
    Woodman RJ, Sirica AE, Gang M, Kline I, Venditti JM.
    Chemotherapy; 1973 Nov; 18(3):169-83. PubMed ID: 4119363
    [No Abstract] [Full Text] [Related]

  • 23. The antileukemic effectiveness of 5-fluorouracil and methotrexate in the combination chemotherapy of advanced leukemia L1210 in mice.
    Kline I, Venditti JM, Mead JA, Tyrer DD, Goldin A.
    Cancer Res; 1966 May; 26(5):848-52. PubMed ID: 5934795
    [No Abstract] [Full Text] [Related]

  • 24. [Combined effect of HO-221 with various antitumor agents against L 1210 leukemia].
    Nakajima T, Masuda H, Okamoto T, Watanabe M, Yokoyama K, Yamada N, Tsukagoshi S, Taguchi T.
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):555-62. PubMed ID: 2012397
    [Abstract] [Full Text] [Related]

  • 25. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
    Siddik ZH, al-Baker S, Thai G, Khokhar AR.
    Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
    [Abstract] [Full Text] [Related]

  • 26. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
    Klubes P, Cerna I.
    Cancer Treat Rep; 1981 Apr; 65(1-2):107-14. PubMed ID: 7226161
    [Abstract] [Full Text] [Related]

  • 27. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J, Robak T, Warzocha K, Grieb P.
    Arch Immunol Ther Exp (Warsz); 1994 Apr; 42(1):39-42. PubMed ID: 7503633
    [Abstract] [Full Text] [Related]

  • 28. The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors.
    Neil GL, Homan ER.
    Cancer Res; 1973 Apr; 33(4):895-901. PubMed ID: 4696483
    [No Abstract] [Full Text] [Related]

  • 29. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).
    Suzumura Y, Kato T, Ueda R, Ota K.
    Anticancer Res; 1989 Apr; 9(4):1083-8. PubMed ID: 2817790
    [Abstract] [Full Text] [Related]

  • 30. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
    Krosnick JA, Mulé JJ, McIntosh JK, Rosenberg SA.
    Cancer Res; 1989 Jul 15; 49(14):3729-33. PubMed ID: 2736513
    [Abstract] [Full Text] [Related]

  • 31. Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.
    Burchenal JH, Kalaher K, O'Toole T, Chisholm J.
    Cancer Res; 1977 Sep 15; 37(9):3455-7. PubMed ID: 884687
    [Abstract] [Full Text] [Related]

  • 32. The influence of recombinant human tumor necrosis factor-alpha, alone and in combination with cyclophosphamide or methotrexate, on leukemia L1210 and normal hematopoiesis in mice.
    Warzocha K, Robak T, Korycka A, Graczyk J, Pakulska W, Gałazka G, Kłysik J.
    Arch Immunol Ther Exp (Warsz); 1991 Sep 15; 39(5-6):587-95. PubMed ID: 1841555
    [Abstract] [Full Text] [Related]

  • 33. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
    Li LH, Wallace TL, Richard KA, Tracey DE.
    Cancer Res; 1985 Feb 15; 45(2):532-8. PubMed ID: 3967227
    [Abstract] [Full Text] [Related]

  • 34. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J, Robak T.
    Acta Haematol Pol; 1993 Feb 15; 24(2):177-82. PubMed ID: 8103959
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
    Kline I, Gang M, Tyrer DD, Venditti JM, Artis EW, Goldin A.
    Cancer Chemother Rep 2; 1972 Nov 15; 3(1):1-69. PubMed ID: 4660732
    [No Abstract] [Full Text] [Related]

  • 36. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.
    Schmid FA, Hutchison DJ, Otter GM, Stock CC.
    Cancer Treat Rep; 1976 Jan 15; 60(1):23-7. PubMed ID: 1000516
    [Abstract] [Full Text] [Related]

  • 37. Potentiating action of 5-fluorouracil when used in combination with platinium compounds and cyclophosphamide in treatment of advanced L1210 leukemia.
    Gale GR, Atkins LM, Schwartz P, Meischen SJ.
    Bioinorg Chem; 1978 Jan 15; 8(5):445-51. PubMed ID: 687671
    [Abstract] [Full Text] [Related]

  • 38. Antileukemic properties of dichloro(1,2-diaminocyclohexane)platinum(II).
    Gale GR, Walker EM, Atkins LM, Smith AB, Meischen SJ.
    Res Commun Chem Pathol Pharmacol; 1974 Mar 15; 7(3):529-38. PubMed ID: 4824827
    [No Abstract] [Full Text] [Related]

  • 39. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
    Goddard P, Valenti M, Kelland LR.
    Anticancer Res; 1994 Mar 15; 14(3A):1065-70. PubMed ID: 8074451
    [Abstract] [Full Text] [Related]

  • 40. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
    Li LH, DeKoning TF, Wallace TL.
    Cancer Res; 1987 Nov 15; 47(22):5894-900. PubMed ID: 3664490
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.